- Home
- LNW vs QGEN Comparison
LNW vs QGEN Comparison
Compare LNW & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- QGEN
- Stock Information
- Founded
- LNW 1984
- QGEN 1986
- Country
- LNW United States
- QGEN Netherlands
- Employees
- LNW N/A
- QGEN N/A
- Industry
- LNW EDP Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LNW Technology
- QGEN Health Care
- Exchange
- LNW Nasdaq
- QGEN Nasdaq
- Market Cap
- LNW 8.4B
- QGEN 9.7B
- IPO Year
- LNW N/A
- QGEN 1996
- Fundamental
- Price
- LNW $93.71
- QGEN $42.40
- Analyst Decision
- LNW Buy
- QGEN Buy
- Analyst Count
- LNW 11
- QGEN 9
- Target Price
- LNW $107.36
- QGEN $51.05
- AVG Volume (30 Days)
- LNW 582.1K
- QGEN 917.8K
- Earning Date
- LNW 11-12-2024
- QGEN 11-06-2024
- Dividend Yield
- LNW N/A
- QGEN 3.17%
- EPS Growth
- LNW 141.51
- QGEN N/A
- EPS
- LNW 3.21
- QGEN 0.41
- Revenue
- LNW $3,162,000,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- LNW $11.37
- QGEN $2.68
- Revenue Next Year
- LNW $7.27
- QGEN $5.95
- P/E Ratio
- LNW $28.90
- QGEN $98.41
- Revenue Growth
- LNW 12.41
- QGEN 0.62
- 52 Week Low
- LNW $76.52
- QGEN $39.03
- 52 Week High
- LNW $115.00
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- LNW 44.26
- QGEN 45.99
- Support Level
- LNW $89.85
- QGEN $40.35
- Resistance Level
- LNW $104.91
- QGEN $42.42
- Average True Range (ATR)
- LNW 2.45
- QGEN 0.81
- MACD
- LNW -0.55
- QGEN -0.09
- Stochastic Oscillator
- LNW 22.91
- QGEN 37.40
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).